glp-1 obesity drug news october 21 2025 Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS investigation GLP-1 Agonists Weight Loss Drugs

The key is consistency and variety, ensuring that protein intake remains adequate as children develop lifelong dietary habits

IV, IM, and SubQ formats each offer unique advantages, and the right one depends on your lifestyle, goals, and the advice of a licensed healthcare provider

Side effects and safety 6 Wegovy side effects you need to be aware of Wegovy and Wegovy HD (semaglutide) are GLP-1 weight-loss medicines that can be associated with common stomach side effects like nausea, vomiting and diarrhea

van Dongen, H

Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism